LAVA Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Nov '25 Nov 19, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Market Capitalization	46	25	42	92	142	-
Market Cap Growth	-4.37%	-39.79%	-54.86%	-35.10%	-	-
Enterprise Value	-4	-48	-57	4	4	-
Last Close Price	1.74	0.95	1.58	3.50	5.50	-
PS Ratio	9.38	2.09	6.14	4.75	26.50	-
PB Ratio	3.61	0.90	0.81	1.07	1.20	-
P/TBV Ratio	3.61	0.90	0.81	1.07	1.20	-
P/FCF Ratio	-	-	-	26.62	-	-
P/OCF Ratio	-	-	-	22.76	-	-
EV/Sales Ratio	-	-	-	0.20	0.81	-
EV/FCF Ratio	-	-	-	1.13	-	-
Debt / Equity Ratio	-	0.19	0.12	0.06	0.04	0.54
Debt / FCF Ratio	-	-	-	1.58	-	-
Asset Turnover	0.07	0.13	0.06	0.14	0.07	0.26
Quick Ratio	11.74	4.25	6.42	6.20	11.91	2.36
Current Ratio	12.27	4.40	6.64	6.40	12.14	2.48
Return on Equity (ROE)	-101.51%	-63.49%	-60.95%	-31.22%	-67.24%	-236.57%
Return on Assets (ROA)	-19.92%	-17.67%	-22.13%	-15.41%	-34.13%	-62.63%
Return on Invested Capital (ROIC)	-51.84%	-35.63%	-36.41%	-20.28%	-40.40%	-94.97%
Return on Capital Employed (ROCE)	-45.20%	-41.10%	-50.00%	-28.70%	-34.10%	-111.60%
Earnings Yield	-50.65%	-100.42%	-100.80%	-34.68%	-29.88%	-
FCF Yield	-67.20%	-78.24%	-98.74%	3.76%	-20.75%	-
Buyback Yield / Dilution	0.86%	-0.38%	-3.12%	-31.21%	-4850.36%	10.81%

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q